Warning! GuruFocus detected
1 Severe warning sign
with PPBT.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Purple Biotech Ltd
ISIN : US49803V1070
Share Class Description:
PPBT: ADRCompare
Compare
Traded in other countries / regions
PPBT.IsraelPPBT.USA1YI.Germany IPO Date
2015-11-20Description
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 46.57 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -26.5 | |||||
| 3-Year EPS without NRI Growth Rate | -53.7 | |||||
| 3-Year FCF Growth Rate | -71 | |||||
| 3-Year Book Growth Rate | -44.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.32 | |||||
| 9-Day RSI | 39.38 | |||||
| 14-Day RSI | 39.9 | |||||
| 3-1 Month Momentum % | -19.9 | |||||
| 6-1 Month Momentum % | -49 | |||||
| 12-1 Month Momentum % | -77.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.23 | |||||
| Quick Ratio | 2.23 | |||||
| Cash Ratio | 2.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -42.7 | |||||
| Shareholder Yield % | -79.8 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -23.08 | |||||
| ROA % | -18.82 | |||||
| ROIC % | -36.05 | |||||
| 3-Year ROIIC % | 94.6 | |||||
| ROC (Joel Greenblatt) % | -1970.87 | |||||
| ROCE % | -23.15 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.22 | |||||
| Price-to-Tangible-Book | 1.29 | |||||
| EV-to-EBIT | 0.18 | |||||
| EV-to-Forward-EBIT | -0.13 | |||||
| EV-to-EBITDA | 0.18 | |||||
| EV-to-FCF | 0.09 | |||||
| Price-to-Net-Current-Asset-Value | 1.72 | |||||
| Price-to-Net-Cash | 1.72 | |||||
| Earnings Yield (Greenblatt) % | 555.56 | |||||
| FCF Yield % | -196.92 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PPBT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Purple Biotech Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -5.99 | ||
| Beta | 0.71 | ||
| 3-Year Sharpe Ratio | -0.76 | ||
| 3-Year Sortino Ratio | -0.97 | ||
| Volatility % | 117.59 | ||
| 14-Day RSI | 39.9 | ||
| 14-Day ATR ($) | 0.201853 | ||
| 20-Day SMA ($) | 2.80002 | ||
| 12-1 Month Momentum % | -77.2 | ||
| 52-Week Range ($) | 2 - 20.6 | ||
| Shares Outstanding (Mil) | 2.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Purple Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Purple Biotech Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Purple Biotech Ltd Frequently Asked Questions
What is Purple Biotech Ltd(PPBT)'s stock price today?
The current price of PPBT is $2.81. The 52 week high of PPBT is $20.60 and 52 week low is $2.00.
When is next earnings date of Purple Biotech Ltd(PPBT)?
The next earnings date of Purple Biotech Ltd(PPBT) is 2025-05-16 Est..
Does Purple Biotech Ltd(PPBT) pay dividends? If so, how much?
Purple Biotech Ltd(PPBT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers